Scott Tarriff is CEO at EAGLE PHARMACEUTICALS, INC. (EGRX). They have made 13 open-market trades across 1 company since 2015, most recently 2024-02-28.
CIK 0001469124
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EGRX | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $13.84 | $599K | -37.5% | -55.7% | -56.9% |
| EGRX | SELL · 10b5-1 | 2023-10-02 | 2023-10-04 | $14.81 | $589K | -5.2% | +0.3% | -60.6% |
| EGRX | SELL | 2023-05-16 | 2023-05-18 | $19.98 | $300K | -0.4% | -5.4% | -16.5% |
| EGRX | SELL | 2023-05-11 | 2023-05-15 | $20.58 | $1.2M | -1.9% | -14.5% | -13.5% |
| EGRX | SELL | 2019-04-01 | 2019-04-03 | $50.15 | $2.5M | -4.8% | +2.4% | +11.9% |
| EGRX | SELL | 2019-03-01 | 2019-03-04 | $51.39 | $1.9M | -3.6% | +2.1% | +5.5% |
| EGRX | SELL | 2019-02-01 | 2019-02-04 | $41.52 | $1.2M | -4.0% | +13.6% | +26.2% |
| EGRX | SELL | 2019-02-01 | 2019-02-04 | $41.54 | $1.2M | -4.0% | +13.6% | +26.2% |
| EGRX | SELL | 2019-01-02 | 2019-01-04 | $39.40 | $2.1M | +0.5% | +2.3% | +21.0% |
| EGRX | SELL | 2016-04-01 | 2016-04-05 | $40.63 | $2.5M | -6.1% | -8.5% | +3.5% |
| EGRX | SELL | 2016-03-01 | 2016-03-03 | $63.20 | $2.5M | -14.5% | -39.1% | -25.6% |
| EGRX | SELL | 2016-02-01 | 2016-02-02 | $68.08 | $1.2M | -14.6% | -3.3% | -41.4% |
| EGRX | SELL | 2016-02-01 | 2016-02-02 | $68.08 | $1.2M | -14.6% | -3.3% | -41.4% |
| EGRX | SELL | 2016-01-04 | 2016-01-05 | $85.91 | $1.2M | -8.3% | -26.3% | -52.4% |
| EGRX | SELL | 2016-01-04 | 2016-01-05 | $85.91 | $1.2M | -8.3% | -26.3% | -52.4% |
| EGRX | SELL · 10b5-1 | 2015-12-01 | 2015-12-02 | $88.93 | $1.2M | -8.4% | -0.4% | -22.3% |
| EGRX | SELL · 10b5-1 | 2015-11-02 | 2015-11-03 | $64.63 | $1.2M | -8.4% | -0.4% | -17.6% |
| EGRX | SELL · 10b5-1 | 2015-10-01 | 2015-10-05 | $69.92 | $1.2M | -8.4% | -0.4% | -0.4% |
| EGRX | SELL · 10b5-1 | 2015-09-01 | 2015-09-03 | $76.95 | $1.2M | -8.4% | -0.4% | -0.4% |
| EGRX | SELL · 10b5-1 | 2015-08-03 | 2015-08-04 | $96.19 | $1.3M | -8.4% | -0.4% | -0.4% |
| EGRX | SELL · 10b5-1 | 2015-03-20 | 2015-07-02 | $46.34 | $6.3M | -8.4% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.